Beneficial effect of the GLP-1 analogue liraglutide on blood pressure and cardiovascular biomarkers in subjects with Type 2 diabetes

被引：0
|
作者：
Vilsboell, T.
Zdravkovic, M.
Le-Thi, T.
Krarup, T.
Schmitz, O.
Courreges, J.
Verhoeven, R.
Buganova, I.
Madsbad, S.
机构：
[1] Gentofte Univ Hosp, Dept Internal Med, Copenhagen, Denmark
[2] Novo Nordisk AS, Clin Res Liraglutide, DK-2880 Bagsvaerd, Denmark
[3] Aarhus Univ, Dept Internal Med, Aarhus, Denmark
[4] Ctr Hosp Narbonne, Med Serv, Narbonne, France
[5] Poli Interne Geneeskunde, Gelre Ziekenhuizen, Apeldoorn, Netherlands
来源：
DIABETIC MEDICINE | 2007年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3 / 3
页数：1
相关论文
共 50 条
  • [31] Acute Metabolic Effects of GLP-1 Analogue in Type 1 Diabetes
    Ghazi, Tara
    Rink, Linda
    Sherr, Jennifer L.
    Herold, Kevan C.
    DIABETES, 2013, 62 : A264 - A264
  • [32] Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
    Horowitz, Michael
    Flint, Anne
    Jones, Karen L.
    Hindsberger, Charlotte
    Rasmussen, Mads F.
    Kapitza, Christoph
    Doran, Selena
    Jax, Thomas
    Zdravkovic, Milan
    Chapman, Ian M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 97 (02) : 258 - 266
  • [33] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [34] EFFECT OF GLP-1 ANALOGUE LIRAGLUTIDE ON PREVENTION OF CARDIOMYOCYTES APOPTOSIS INDUCED BY ANOXIA/REOXYGENATION
    Shen, Y. F.
    Liu, M. M.
    Chen, C.
    Lai, X. Y.
    Zhang, M. Y.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S227 - S228
  • [35] Liraglutide. GLP-1 receptor agonist, Treatment of type 2 diabetes, Treatment of obesity
    Gallwitz, B.
    DRUGS OF THE FUTURE, 2008, 33 (01) : 13 - 20
  • [36] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
    Kapitza, Christoph
    Flint, Anne
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [37] The Novel Use of GLP-1 Analogue and Insulin Combination in Type 2 Diabetes Mellitus
    Baruah, Manash P.
    Kalra, Sanjay
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2012, 6 (02) : 129 - 135
  • [38] Overview of the design of the phase 3 studies for the long-acting human GLP-1 analogue liraglutide: Liraglutide effect and action in diabetes (LEAD)
    Zdravkovic, Milan
    Hale, Paula
    Lethi, Tu D.
    Kristensen, Peter
    DIABETES, 2007, 56 : A571 - A571
  • [39] SGLT2 inhibitor and GLP-1 analogue combination therapy in Type 2 diabetes
    Bashir, J.
    Stephens, J.
    Anderson, R.
    Hayes, J.
    Elamin, O.
    Lloyd, A.
    DIABETIC MEDICINE, 2016, 33 : 165 - 166
  • [40] Cardiovascular benefits of GLP-1 agonists in type 2 diabetes: a comparative review
    Boyle, James G.
    Livingstone, Rachel
    Petrie, John R.
    CLINICAL SCIENCE, 2018, 132 (15) : 1699 - 1709
12345